IGF2BP2 and acute myeloid leukemia: IGF2BP2 levels can also use as a prognostic indicator of acute myelocytic leukemia 25, breast cancer 53, endometrial adenocarcinoma 54, liposarcoma 55, pancreatic cancer 27, hepatocellular carcinoma 30 and OSCC 35.